Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Estriol suppository before colposcopy in postmenopausal women
ChiCTR2500095868Phase 4Recruiting
- Sponsor
- The Second Xiangya Hospital
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of estriol in Cervical Cancer (CC) (2 arms), sponsored by The Second Xiangya Hospital. Primary endpoint: Proportion of adequate colposcopy. Started Jan 2025; status: recruiting.
02
Drugs
estriol
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on ChiCTR2500095868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500095868.